drugset / Trial / NCT00150540

A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.

NCT00150540

Phase 3 Completed 93 enrolled Shire
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety of lanthanum carbonate in patients undergoing dialysis who have received lanthanum carbonate in the previous studies and wish to continue treatment.

Timeline

Start
2002-10-14
Primary completion
2005-06-29
Completion
2005-06-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Lanthanum Carbonate Other / unclassified